VisionCare Ophthalmic Technologies Inc. will increase the potential market for its Implantable Miniature Telescope to treat macular degeneration patients by about 30 to 35 percent based on an expanded indication approved by FDA, the firm said.
FDA approved the firm's PMA supplement for use of the device in patients 65 years and older, VisionCare said Oct. 13. Previously, the device was only approved for those 75...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?